Robot-assisted radiotherapy represents a significant leap forward in the treatment of eye diseases. Published in The Lancet, a pioneering trial underscores its potential by showing substantial reductions in the necessity for injections to manage conditions, potentially cutting global injection needs by up to 1.8 million annually.